Oct 23, 2026 · 59 min
Theranos’s shadow follows Holmes and her new business partner
What’s the Deal With Billy Evans? A Spoiler-Filled Guide to ‘You Can See Everything’
The episode tests whether the Theranos scandal is repeating itself around Elizabeth Holmes while tracing the financial and political risks surrounding today’s tech boom.
- 1Billy Evans’s Hemanthus faces scrutiny over its product, funding, regulatory claims, and the documentary’s portrayal of the startup.
- 2John Carreyrou argues that Elizabeth Holmes knowingly managed Theranos’s deception and continues to avoid meaningful responsibility for its harm.
- 3The broader conversation links controversial founders to investor faith, AI infrastructure debt, corporate consolidation, and political influence.
Don't miss
John Carreyrou rejects Holmes’s claim that she was merely confused or imprecise, arguing that her control of Theranos makes those defenses untenable.
The brief
Rob Copeland reports on Hemanthus, Billy Evans’s blood-testing startup with Elizabeth Holmes, finding a gap between its documentary portrayal and questions about its product, funding, and regulatory claims.
The hosts examine Holmes and Evans’s relationship, asking whether romance, business, notoriety, and political transformation have become inseparable in the couple’s public story.
The episode widens its lens to CoreWeave’s debt, a possible SpaceX-Tesla merger, and Joel Kaplan’s exit from Meta, connecting founder power to institutional risk.
John Carreyrou revisits Theranos’s promises, whistleblower intimidation, and Holmes’s defenses, arguing that her control of the company makes claims of confusion unpersuasive.
Carreyrou’s sharpest judgment is that Holmes continues to perform innocence, while Evans appears both drawn into her notoriety and willing to exploit it.
Books & mentions
Some links are affiliate links — PodLume may earn a commission if you buy.
Weekly email
State of the Pod, every Monday
The week's most-discussed names and stories from podcasts, with the moments behind them. Free, five minutes, unsubscribe in one click.